STUDY ON THE EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SLOVAKIA: ONE YEAR RESULTS OF PROSPECTIVE, OPEN LABEL STUDY CLOSE TO CLINICAL PRACTICE

被引：0
|
作者：
Rybar, I. [1 ]
Killinger, Z. [2 ]
Macejova, Z. [3 ]
Kmecova, Z. [4 ]
Zanova, E. [5 ]
Rovensky, J. [5 ]
机构：
[1] Slovak Med Univ, Dept Rheumatol, Piestany, Slovakia
[2] Comenius Univ, Sch Med, Dept Internal Med 5, Bratislava, Slovakia
[3] Safarik Univ, Sch Med, Dept Internal Med 1, Kosice, Slovakia
[4] Slovak Med Univ, Dept Internal Med 2, Banska Bystrica, Slovakia
[5] Slovak Med Univ, Dept Rheumatol, Bratislava, Slovakia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1516
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0428
引用
收藏
页码：948 / 949
页数：2
相关论文
共 50 条
  • [31] CLINICAL EFFICACY OF TOCILIZUMAB IN POLYMYALGIA RHEUMATICA: AN OPEN-LABEL STUDY
    Toussirot, E.
    Martin, A.
    Soubrier, M.
    Redeker, S.
    Regent, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 516 - 516
  • [32] Clinical Efficacy of Tocilizumab in Polymyalgia Rheumatica: An OPEN-Label Study
    Toussirot, Eric
    Martin, Antoine
    Soubrier, Martin
    Redeker, Serge
    Regent, Alexis
    Cri, Le
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis - A three-year study in Taiwan
    Lin, Ching-Tsai
    Huang, Wen-Nan
    Hsieh, Chia-Wei
    Chen, Yi-Ming
    Chen, Der-Yuan
    Hsieh, Tsu-Yi
    Chen, Yi-Hsing
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (01) : 141 - 150
  • [34] Efficacy, Safety and Continuation Rate of Abatacept and Tocilizumab in Patients with Rheumatoid Arthritis : The Comparative Observational Study
    Matsuda, Mayumi
    Asanuma, Yu Funakubo
    Wada, Takuma
    Kouzu, Noritsune
    Sato, Kojiro
    Mimura, Toshihide
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [35] Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
    Kavanaugh, Arthur
    Westhovens, Rene R.
    Winthrop, Kevin L.
    Lee, Susan J.
    Tan, YingMeei
    An, Di
    Ye, Lei
    Sundy, John S.
    Besuyen, Robin
    Meuleners, Luc
    Stanislavchuk, Mykola
    Spindler, Alberto J.
    Greenwald, Maria
    Alten, Rieke
    Genovese, Mark C.
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (08) : 1230 - 1238
  • [36] Analysis of effectiveness, safety and optimization of tocilizumab in a cohort of patients with rheumatoid arthritis in clinical practice
    Mena-Vazquez, Natalia
    Manrique-Arija, Sara
    Rojas-Gimenez, Marta
    Urena-Garnica, Inmaculada
    Jimenez-Nunez, Francisco G.
    Fernandez-Nebro, Antonio
    REUMATOLOGIA CLINICA, 2019, 15 (01): : 21 - 26
  • [37] Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis
    Shergy, WJ
    Isern, RA
    Cooley, DA
    Harshbarger, JL
    Huffstutter, JE
    Hughes, GM
    Spencer-Smith, EA
    Goldman, AL
    Roth, SH
    Toder, JS
    Warner, D
    Quinn, A
    Keenan, GF
    Schaible, TF
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (04) : 667 - 677
  • [38] Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
    Vivian P. Bykerk
    Andrew J. K. Östör
    José Alvaro-Gracia
    Karel Pavelka
    José Andrés Román Ivorra
    Winfried Graninger
    William Bensen
    Michael T. Nurmohamed
    Andreas Krause
    Corrado Bernasconi
    Maher Aassi
    Jean Sibilia
    Clinical Rheumatology, 2015, 34 : 1321 - 1321
  • [39] Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study
    Ogata, Atsushi
    Amano, Koichi
    Dobashi, Hiroaki
    Inoo, Masayuki
    Ishii, Tomonori
    Kasama, Tsuyoshi
    Kawai, Shinichi
    Kawakami, Atsushi
    Koike, Tatsuya
    Miyahara, Hisaaki
    Miyamoto, Toshiaki
    Munakata, Yasuhiko
    Murasawa, Akira
    Nishimoto, Norihiro
    Ogawa, Noriyoshi
    Ojima, Tomohiro
    Sano, Hajime
    Shi, Kenrin
    Shono, Eisuke
    Suematsu, Eiichi
    Takahashi, Hiroki
    Tanaka, Yoshiya
    Tsukamoto, Hiroshi
    Nomura, Akira
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (05) : 799 - 809
  • [40] Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid Arthritis
    Keystone, Edward C.
    Genovese, Mark C.
    Schlichting, Douglas E.
    de la Torre, Inmaculada
    Beattie, Scott D.
    Rooney, Terence P.
    Taylor, Peter C.
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (01) : 14 - 21
12345